Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus

被引:40
|
作者
Jia, L [1 ]
Coetzee, GA [1 ]
机构
[1] Univ So Calif, Norris Canc Ctr, Keck Sch Med, Dept Urol & Prevent Med, Los Angeles, CA 90089 USA
关键词
D O I
10.1158/0008-5472.CAN-04-3679
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is widely suspected that androgen-independent prostate cancer growth depends on androgen receptor signaling via ill-defined mechanisms. Prostate-specific antigen (PSA) expression is often used to measure androgen receptor activity in cells and prostate cancer progression in patients. In the present study, we have compared androgen receptor activity using PSA and human male germ cell-associated kinase (WAK), as read-outs in androgen-dependent LNCaP and androgen-independent C4-2B cells. As expected, very little PSA and hMAK expression were detected in LNCaP cells in the absence of androgens, whereas substantial expression of PSA was observed only in C4-2B cells under the same conditions. The addition of dilrydrotestosterone to the culture medium increased the expression of both genes in both cell types. Comprehensive chromatin immunoprecipitation analysis of the entire PSA locus and an androgen-response element in hMAK unexpectedly revealed that androgen receptor was not occupying any site in the absence of dilrydrotestosterone in either cell type. In line with the expression data, and in the absence of dihydrotestosterone, histone acetylation and RNA polymerase 11 occupancy was substantial at the PSA locus in C4-2B but not in LNCaP cells. In the presence of dihydrotestosterone, androgen receptor was found to occupy mainly the enhancer region of PSA in both cell types, accompanied with increases in historic acetylation and RNA polymerase 11 occupancy. Although the androgen receptor was not directly involved in the androgen-independent expression of PSA in C4-2B cells, small interfering RNA knock-down of androgen receptor significantly reduced PSA expression in both the presence and absence of dilrydrotestosterone. In contrast, hMAK expression was decreased only in the presence of dihydrotestosterone after androgen receptor knock-down. We conclude that androgen-independent expression of PSA in C42B cells does not rely on the direct occupancy of the androgen receptor at the PSA locus, but is nevertheless affected indirectly via unknown androgen receptor-dependent mechanism(s) that influence the expression from some but not all androgen receptor target genes.
引用
收藏
页码:8003 / 8008
页数:6
相关论文
共 50 条
  • [21] Establishment and Characterization of an Androgen Receptor-Dependent, Androgen-Independent Human Prostate Cancer Cell Line, LNCaP-CS10
    Ishikura, Nobuyuki
    Kawata, Hiromitsu
    Nishimoto, Ayako
    Nakamura, Ryo
    Ishii, Nobuya
    Aoki, Yuko
    PROSTATE, 2010, 70 (05): : 457 - 466
  • [22] Nuclear localization of Src, androgen receptor and PSA in prostate cancer
    Saxena, Parmita
    Wang, Tao
    Adams, Dave S.
    Gioeli, Daniel
    FitzGerald, Thomas J.
    Languino, Lucia R.
    CANCER RESEARCH, 2010, 70
  • [23] Androgen receptor expression in androgen independent prostate cancer cell lines
    Chlenski, A
    Nakashiro, K
    Ketels, KV
    Korovaitseva, GI
    Oyasu, R
    PROSTATE, 2001, 47 (01): : 66 - 75
  • [24] LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
    Li, Yirong
    Wang, Longgui
    Zhang, Miao
    Melamed, Jonathan
    Liu, Xiaomei
    Reiter, Robert
    Wei, Jianjun
    Peng, Yi
    Zou, Xuanyi
    Pellicer, Angel
    Garabedian, Michael J.
    Ferrari, Anna
    Lee, Peng
    CANCER RESEARCH, 2009, 69 (08) : 3332 - 3338
  • [25] Simultaneous targeting of the androgen receptor and PI3K/mTOR pathway in androgen-dependent and androgen-independent prostate cancer cells
    Liu, X.
    Gomez-Pinillos, A.
    Ferrari, A. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells
    Moss, Patrice E.
    Lyles, Besstina E.
    Stewart, LaMonica V.
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (20) : 3478 - 3488
  • [27] Heterogeneous androgen receptor (AR) protein expression in metastatic androgen-independent prostate cancer: implications for complex AR mechanisms in the progression to androgen independent prostate cancer
    Shah, RB
    Chinnaiyan, A
    Mehra, R
    Varambally, S
    Shen, R
    Harwood, J
    Bismar, R
    Kim, R
    Pienta, K
    Rubin, MA
    MODERN PATHOLOGY, 2005, 18 : 163A - 163A
  • [28] MUTATION OF THE ANDROGEN-RECEPTOR GENE IN METASTATIC ANDROGEN-INDEPENDENT PROSTATE-CANCER
    TAPLIN, ME
    BUBLEY, GJ
    SHUSTER, TD
    FRANTZ, ME
    SPOONER, AE
    OGATA, GK
    KEER, HN
    BALK, SP
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21): : 1393 - 1398
  • [29] Androgen receptor silencing inhibits growth of androgen-independent LNCaP prostate cancer variants
    Mack, Philip C.
    Burich, Rebekah A.
    White, Ralph W. Devere
    CANCER RESEARCH, 2006, 66 (08)
  • [30] Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
    Xiao-Yan Zhao
    Peter J. Malloy
    Aruna V. Krishnan
    Srilatha Swami
    Nora M. Navone
    Donna M. Peehl
    David Feldman
    Nature Medicine, 2000, 6 : 703 - 706